Consistently, Mihyawi and colleagues observed a lower prevalence and risk of CAD in VWD patients compared to controls, providing epidemiological support for the pathogenic role of the vWF in coronary atherosclerosis [46]. This evidence concerns the gene VWF and coronary atherosclerosis.